Cytomegalovirus-Associated CD4+CD28null Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction

American Journal of Transplantation

Volumn 16, Issue 4, 2016, Pages 1113-1128

  Shabir, S ^a,b   Smith, H ^b   Kaul, B ^b   Pachnio, A ^b   Jham, S ^a,b   Kuravi, S ^b   Ball, S ^a,b   Chand, S ^a,b   Moss, P ^b   Harper, L ^b   Borrows, R ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD27 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; VON WILLEBRAND FACTOR; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ADULT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL HOMING; CELL PROLIFERATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DELAYED GRAFT FUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GLOMERULUS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HLA SYSTEM; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MEMORY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL GRAFT DYSFUNCTION; T LYMPHOCYTE; ADVERSE EFFECTS; ALLOGRAFT; COMPLICATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; INJURIES; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; VASCULAR ENDOTHELIUM; VIROLOGY;

ALLOGRAFTS; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DELAYED GRAFT FUNCTION; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84959432917     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13614     Document Type: Article

References (34)

1. Baron C, Forconi C, Lebranchu Y,. Revisiting the effects of CMV on long-term transplant outcome. Curr Opin Organ Transplant 2010; 15 (4): 492-498.
2. Rubin RH,. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: The end of the 'silo hypothesis'. Curr Opin Infect Dis 2007; 20 (4): 399-407.
3. van Ree RM, de Vries AP, Zelle DM, et al., Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients. Med Sci Monit 2011; 17 (11): CR609-CR617.
4. Betjes MG, Huisman M, Weimar W, Litjens NH,. Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease. Kidney Int 2008; 74 (6): 760-767.
5. Thewissen M, Somers V, Hellings N, Fraussen J, Damoiseaux J, Stinissen P,. CD4+CD28null T cells in autoimmune disease: Pathogenic features and decreased susceptibility to immunoregulation. J Immunol 2007; 179 (10): 6514-6523.
6. Morgan MD, Pachnio A, Begum J, et al., CD4+CD28- T cell expansion in granulomatosis with polyangiitis (Wegener's) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality. Arthritis Rheum 2011; 63 (7): 2127-2137.
7. Weng NP, Akbar AN, Goronzy J,. CD28(-) T cells: Their role in the age-associated decline of immune function. Trends Immunol 2009; 30 (7): 306-312.
8. van Leeuwen EM, Remmerswaal EB, Vossen MT, et al., Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173 (3): 1834-1841.
9. Nakajima T, Schulte S, Warrington KJ, et al., T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002; 105 (5): 570-575.
10. Jensen H, Folkersen L, Skov S,. Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells. PLoS One 2012; 7 (8): e41577.
11. Saez-Borderias A, Guma M, Angulo A, Bellosillo B, Pende D, Lopez-Botet M,. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol 2006; 36 (12): 3198-3206.
12. Smith HJ, Hanvesakul R, Bentall A, et al., T Lymphocyte responses to nonpolymorphic HLA-derived peptides are associated with chronic renal allograft dysfunction. Transplantation 2011; 91 (3): 279-286.
13. Smith HJ, Hanvesakul R, Morgan MD, et al., Chronic graft versus host disease is associated with an immune response to autologous human leukocyte antigen-derived peptides. Transplantation 2010; 90 (5): 555-563.
14. Zhou YF, Shou M, Guetta E, et al., Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 1999; 100 (14): 1569-1575.
15. Sinclair J, Sissons P,. Latency and reactivation of human cytomegalovirus. J Gen Virol 2006; 87 (Pt 7): 1763-1779.
16. Reeves MB, Sinclair JH,. Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo. J Virol 2013; 87 (19): 10660-10667.
17. Kalil AC, Florescu DF,. Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis? Crit Care 2011; 15 (2): 138.
18. Osawa R, Singh N,. Cytomegalovirus infection in critically ill patients: A systematic review. Crit Care 2009; 13 (3): R68.
19. Fasth AE, Dastmalchi M, Rahbar A, et al., T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol 2009; 183 (7): 4792-4799.
20. Mittelbrunn M, Molina A, Escribese MM, et al., VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses. Proc Natl Acad Sci U S A 2004; 101 (30): 11058-11063.
21. Abraham C, Griffith J, Miller J,. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. J Immunol 1999; 162 (8): 4399-4405.
22. Jackson SE, Mason GM, Okecha G, Sisson JG, Wills MR,. Diverse specificity, phenotype and anti-viral activity of cytomegalovirus specific CD8+ T cells. J Virol 2014; 88: 10894-10908.
23. Adler B, Sinzger C,. Endothelial cells in human cytomegalovirus infection: One host cell out of many or a crucial target for virus spread? Thromb Haemost 2009; 102 (6): 1057-1063.
24. Miller-Kittrell M, Sparer TE,. Feeling manipulated: Cytomegalovirus immune manipulation. Virol J 2009; 6: 4.
25. de Menthon M, Lambert M, Guiard E, et al., Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's). Arthritis Rheum 2011; 63 (7): 2116-2126.
26. Bolovan-Fritts CA, Trout RN, Spector SA,. High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood 2007; 110 (6): 1857-1863.
27. Satchell SC, Tasman CH, Singh A, et al., Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 2006; 69 (9): 1633-1640.
28. Sharif A, Borrows R,. Delayed graft function after kidney transplantation: The clinical perspective. Am J Kidney Dis 2013; 62 (1): 150-158.
29. Chapman JR,. Longitudinal analysis of chronic allograft nephropathy: Clinicopathologic correlations. Kidney Int Suppl 2005; 99: S108-S112.
30. van Ree RM, Oterdoom LH, de Vries AP, et al., Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrol Dial Transplant 2007; 22 (1): 246-253.
31. Dahle DO, Mjoen G, Oqvist B, et al., Inflammation-associated graft loss in renal transplant recipients. Nephrol Dial Transplant 2011; 26 (11): 3756-3761.
32. Meier-Kriesche HU, Schold JD, Kaplan B,. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4 (8): 1289-1295.
33. Kotton CN,. CMV: Prevention, Diagnosis and Therapy. Am J Transplant 2013; 13 (Suppl 3): 24-40; quiz 40.
34. Suarez-Alvarez B, Lopez-Vazquez A, Baltar JM, Ortega F, Lopez-Larrea C,. Potential role of NKG2D and its ligands in organ transplantation: New target for immunointervention. Am J Transplant 2009; 9 (2): 251-257.